Whether it comes from a doctor, family member, or a friend, we’ve all heard it before: “Try not to worry.” But in today’s world, having that perspective can feel almost impossible. First-person accounts of current events like recent hurricanes, global tragedies, and more are always just a click away, creating stress and anxiety. Ravi Jandhyala, … Read more
The Mini is a bite-sized version of The New York Times‘ revered daily crossword. While the crossword is a lengthier experience that requires both knowledge and patience to complete, The Mini is an entirely different vibe. With only a handful of clues to answer, the daily puzzle doubles as a speed-running test for many who … Read more
Gallagher’s Q3 results reveal steady growth in key segments | Insurance Business America Insurance News Gallagher’s Q3 results reveal steady growth in key segments Organic expansion and new mergers sustain revenue increases across sectors Insurance News By Kenneth Araullo Arthur J Gallagher & Co (Gallagher) has released its financial results for Q3, ending September 30, … Read more
Countries, including the US, specify the need for human operators to “exercise appropriate levels of human judgment over the use of force” when operating autonomous weapon systems. In some instances, operators can visually verify targets before authorizing strikes and can “wave off” attacks if situations change. AI is already being used to support military targeting. … Read more
NYSE:PLX John Viglotti: Hello, and welcome to Virtual Investor Conferences. My name is John Viglotti, and on behalf of OTC Markets and our co-host, Zacks Small Cap Research, we’re very pleased you joined us for our next presentation from Protalix Biotherapeutics. Their session will be moderated by John Vandermosten. He’s the Senior Biotechnology Analyst with … Read more
